# Phase 10 — Formal Production Go/No-Go

Assessment date: **2026-08-15**  
Decision state: **`NO-GO / BLOCKED — PLATFORM INDUSTRIALISATION REQUIRED`**

## Purpose

Phase 10 is the accountable production-authorization gate for the accepted DTMO release candidate. It separates production authorization from repository engineering, staging validation and independent assurance.

## Accepted prerequisites

The accepted release line includes E8.1–E8.10 `PASS / REPOSITORY_COMPLETE`. The accountable owner reported the following prerequisites complete:

- Phase 8.2 platform and identity validation — `PASS`;
- Phase 8.3 source-to-intelligence validation — `PASS`;
- Phase 8.4 operations, recovery and rollback validation — `PASS`;
- Phase 8.5 accountable staging acceptance — `PASS / OWNER_ACCEPTED`;
- Phase 9 independent external assurance — `PASS / EXTERNAL_ASSURANCE_ACCEPTED`.

These status updates are owner-supplied acceptance facts. Repository CI must not be represented as the source of the external Phase 8 or independent Phase 9 decisions.

## Accountable decision

**Decision: `NO-GO / BLOCKED`.**

The current product is not authorized for production. The decision is not a rejection of the accepted functional, staging or assurance evidence; it is a strategic production-readiness decision that the platform should first be industrialised around mature, maintainable open-source subsystems rather than continue expanding DTMO as a monolithic implementation.

The successor programme is **Phase 11 — Platform Industrialisation**, followed by a new **Phase 12 — Production GO/NO-GO** decision for the materially changed integrated platform.

**Current successor state:** Phase 11 is `IN PROGRESS / ACTIVE`; Phase 12 is `NOT STARTED`.

Primary reasons for the no-go:

1. generic OSINT collection and analyst workflow should be integrated with Taranis AI instead of duplicated further in DTMO;
2. generic IOC enrichment should use a mature subsystem, with IntelOwl as the preferred first integration;
3. CTI relationship/knowledge-graph requirements should be delegated to OpenCTI rather than implemented as a new DTMO graph engine;
4. MISP capabilities across DTMO/Taranis require one authoritative governed sharing model;
5. incident/case workflow should integrate with TheHive rather than become custom DTMO case management;
6. the composed platform requires Kubernetes/Helm/GitOps, HA, secrets, identity, observability, backup/recovery and supply-chain hardening as one integrated production architecture;
7. the material architecture change invalidates reuse of Phase 8/9 evidence as production authorization for the future integrated candidate.

## Evidence effect

The Phase 8 and Phase 9 evidence remains valid historical evidence for the candidate it covered. It must not be rewritten or discarded.

However, the Phase 11 integrated platform will be a materially changed candidate. Therefore:

- prior Phase 8 staging acceptance does not automatically accept the future integrated deployment;
- prior Phase 9 independent assurance does not automatically assure the future integrated deployment;
- repository CI cannot bridge that evidence gap;
- Phase 11 requires new production-equivalent validation and independent external assurance before Phase 12.

## Successor programme

The authoritative successor roadmap is:

- `docs/roadmap/PLATFORM_INDUSTRIALISATION_ROADMAP.md`;
- `docs/architecture/TARANIS_PLATFORM_INTEGRATION_ASSESSMENT.md`.

The fixed integration priority is Taranis AI → IntelOwl → OpenCTI → MISP consolidation → TheHive → Cortex only if justified → integrated runtime industrialisation → migration/compatibility → production-equivalent validation → independent assurance.

## Production status

DTMO remains **not production authorized**. No production deployment should be represented as approved under this Phase 10 decision.

## Next production decision

A new production authorization decision occurs only in **Phase 12**, after Phase 11 production-equivalent validation and independent external assurance are complete against one immutable integrated release identity.

The Phase 12 decision remains fail-closed and does not grant autonomous publication or external-sharing authority.